Injuries to the growth plate in children can result in bone bridge formation, which ultimately lead to limb length and angular deformities. The histological and molecular changes associated with growth plate repair following the LangenskiΓΆld procedure, a surgical technique used to remove impeding bo
Study of recombinant human osteogenic protein-1 expressed in prokaryocyte on the repair of extracted socket in rabbits
β Scribed by Yi Liu; Jin-Xiang Han; Shui-Qing Xiao; Shi-Li Wang; Min Wang
- Publisher
- John Wiley and Sons
- Year
- 2006
- Tongue
- English
- Weight
- 323 KB
- Volume
- 77A
- Category
- Article
- ISSN
- 1549-3296
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
The study investigated the effect of recombinant human osteogenic proteinβ1 (rhOPβ1) expressed in prokaryocyte, to promote the healing of alveolar socket. A model of rabbit extracted socket into which the composites of rhOPβ1 and gelatin sponge was immediately implanted was created and the osteoinduction of rhOPβ1 was assessed by histological method, quantitative measurement of calcium content and alkaline phosphatase (ALP) activity. The result of histology showed that bone healing in rhOPβ1 side is 4β6 weeks earlier than that of the control side. ALP activity and calcium content in rhOPβ1 side were significantly high compared with that of the control side. rhOPβ1 has a satisfactory osteoinduction ability to promote the healing of extracted socket. Β© 2006 Wiley Periodicals, Inc. J Biomed Mater Res, 2006
π SIMILAR VOLUMES
In this study, the temporal and spatial expression of the chemotactic factor monocyte chemotactic protein-1 (MCP-1) was examined in the rabbit retina after challenge with the proinflammatory cytokine interleukin-1β€ (IL-1). In these tissues, IL-1 induces an acute inflammatory response of the epiretin
Signal transduction initiated by TGFb1 and OP-1 was studied in MG63 human osteosarcoma cells and in normal human bone cells (HBCs) in the presence of inhibitors of signal transduction events, using insulinlike growth factor binding protein-3 (IGFBP-3) production as an end point. Treatment of serum-f